Target intelligence / Profile preview

Arginine-specific gingipain A (HRgpA)

Target
HRgpA
Molecular classification
Cysteine protease, Enzyme, Hydrolase, Bacterial virulence factor
01

Overview

Gingipain HRgpA (Arginine-specific gingipain A) is a major extracellular cysteine protease produced by the gram-negative bacterium Porphyromonas gingivalis, a primary pathogen in chronic periodontitis [1]. Unlike its counterpart RgpB, HRgpA is a large complex consisting of a catalytic domain and several non-catalytic adhesion/hemagglutinin domains, which facilitate bacterial attachment to host tissues and the acquisition of essential nutrients like heme [2][4]. Biologically, HRgpA plays a critical role in host immune system evasion by degrading cytokines, complement proteins, and antimicrobial peptides, while also contributing to tissue destruction through the breakdown of extracellular matrix proteins [3]. Recent clinical research has identified gingipains, including HRgpA, in the brains of Alzheimer's disease patients, suggesting a role in neurodegeneration via the promotion of tau phosphorylation and neurotoxicity [2]. Therapeutic strategies focus on small-molecule inhibitors that target the enzyme's catalytic site to block its proteolytic activity, with compounds like COR271 being investigated for their potential to mitigate both periodontal damage and associated systemic or neurological pathologies [2]. Sources: [1] UniProt (P28784): RGP1_PORGI - Arginine-specific gingipain A. [2] Dominy SS, et al. (2019). "Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors." Science Advances. [3] Imamura T. (2003). "The role of gingipains in the pathogenesis of periodontal disease." Journal of Periodontology. [4] Potempa J, et al. (2015). "Gingipains: the major virulence determinants of Porphyromonas gingivalis." Molecular Oral Microbiology.

Other names
Arg-gingipain AGingipain R1RGP-1RgpAArginine-specific cysteine proteinaseHigh molecular weight Arg-gingipain A
02

Mechanism of action

Inhibition of the cysteine protease catalytic activity by binding to the active site, thereby preventing the cleavage of host proteins and bacterial nutrient acquisition.

03

Biological functions

ProteolysisCell adhesionHeme acquisitionImmune evasionPathogenesis
04

Disease associations

PeriodontitisAlzheimer's diseaseRheumatoid arthritisAtherosclerosis
05

Safety considerations

Hepatotoxicity (liver enzyme elevation)Oral microbiome dysbiosisPotential for bacterial resistance
06

Interacting drugs

COR271

1 more in the full profile.

07

Biomarkers

Porphyromonas gingivalis DNAGingipain levels in Gingival Crevicular Fluid (GCF)Anti-gingipain antibodies

Beyond the preview

Go deeper on Arginine-specific gingipain A (HRgpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine-specific gingipain A (HRgpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call